Cannabis Events Plan Comeback, Anticipating End of Pandemic
1 min readPublished On: March 5th, 2021By News Team
LOS ANGELES – The cannabis events circuit is coming back to life after the long hiatus because of the pandemic. Of the recent events announced, these include the annual Cannabis Business Summit & Expo is back on later this year. August 3-5 in San Francisco at the Moscone Center. Organized by the National Cannabis Industry Association, it’s one of the important networking events back on the calendar in cannabis. (Images in this article are from Hall Of Flowers).
Hall of Flowers is back on for September 22-23 in Santa Rosa, at the Sonoma County Fairgrounds in California. ”HOF” is one of the highlights of the Cannabis conference circuit.
The socializing & networking and inexpensive cannabis brand giveaways and samples…are legendary.
The organizers say the dates are reserved and they’re ready to return to business but given 2020, ask you refrain from booking your travel just yet. They can use your support as this event is their ”bread & butter.”
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Pharmaceuticals Inc. announced today the peer-reviewed publication of its sponsored preclinical study titled "The Effect of Isolated Cannabinoid Extracts on Polypoid Colorectal Tissue" in the International Journal of Molecular Sciences; concluding "possible future therapeutic value" for the ...
LAS VEGAS, Sept. 29, 2022 Hippo Premium Packaging a provider of custom packaging and branding solutions to the cannabis and hemp industries, specializes in designing beautiful custom packaging for the cannabis and hemp industries. The ...
LANSING, Mich., Sept. 28, 2022 ACT Laboratories, Inc. a testing company in the legal cannabis and hemp markets, today announced an agreement to acquire CDX Analytics, LLC ("CDX") of Massachusetts "ACT Labs is out to build the foremost, ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more